Join the Search to end
childhood
cancer

We find the science most likely to become a treatment. Then we fund it.

CureSearch identifies the most promising childhood cancer research and provides the critical funding needed to move it toward the clinic and the children who need it.

How does CureSearch work? Fund a breakthrough

A smiling young patient resting in a hospital bed

Happening now

We fund where breakthroughs begin.

Moving promising science discovery forward to reach children faster.

How funding moves research forward

Federal & other funding

Early Stage

Basic Research
Drug Discovery & Design

We fund here!

The Gap

Preclinical Development
Early-Phase Clinical Trials

Pharmaceutical funding

Later Development

Late-Phase Trials
FDA Review & Approval

Three smiling children sit together on the grass outdoors

The result

Treatments Widely Available

Treatments begin reaching children in clinical trials

Explore the full funding strategy

A survivor’s perspective

“I lived because someone funded the research that saved me before anyone knew it would work. That is what CureSearch does, and it is why I am proud to serve.”

Wendy ManganaroChildhood cancer survivor · CureSearch Tri-State Community Leadership Board

Who you’re helping

For a life beyond cancer.

Meet Caden Shrauger.

Diagnosed with stage IV neuroblastoma at 3, he survived against the odds. Now a young adult, he’s living CureSearch’s mission: in 2026 alone, he raised over $50,000 through the CureSearch Ultimate Hike to fund research that will lead to safer treatments. His story shows why your support matters. It doesn’t just save lives, it creates a chain of hope that survivors like Caden carry forward.

Read Caden’s story

How you’re helping

You help fund childhood cancer research at the stage where it is most likely to stall, and move it toward the children who need it most. More

20+ pediatric cancer types studied by CureSearch-funded researchers
9,000+ children per year are diagnosed with cancers targeted by our funded trials.

70% of Young Investigators went on to secure federal funding after receiving a CureSearch award
71% of preclinical projects far enough along to assess have advanced to clinical trials
2X+ the typical success rate of new therapies advancing to the clinic